Pharmafile Logo
Pharmafocus logo
Advanced Search

neuroscience

Showing 15 posts of 22 posts found.

robina-weermeijer-ihfopazzjhm-unsplash_5

Cognixion receives FDA Breakthrough Device Designation for assisted communication device

May 5, 2023
Medical Communications Cognixion, FDA, Neurology, brain computer interface, breakthrough device designation, neuroscience

Cognixion, a developer of non-invasive Brain-Computer Interface (BCI) and Augmented Reality (AR) technology, has announced that the US Food and …

News

Axol Bioscience and CENSO Biotechnologies enter merger agreement

March 17, 2021
Research and Development Axol Bioscience, Censo Biotechnologies, immune cell, merger, neuroscience

Axol Bioscience, an established provider of iPSC-derived cells, media, and characterisation services, and CENSO Biotechnologies, a cell biology CRO focused …

News
schizophrenia

Acadia’s schizophrenia drug flops in Phase 3 trial

July 23, 2019
Manufacturing and Production acadia, clinical trials, menatl health, neuroscience, pharma, phase 3, schizophrenia

Acadia Pharmaceuticals has said its schizophrenia drug Nuplazid (primavanserin) has failed to beat placebo in a Phase 3 trial. Nuplazid …

News

Takeda opens R&D facility in San Diego, California

May 2, 2019
Manufacturing and Production, Research and Development CNS, GI, Japan, Takeda, california, neuroscience, san diego

Japanese-firm Takeda pharmaceuticals has opened a new research facility in San Diego, California. The 165,000ft2 research centre will employ 250 …

News
astrocyte5

Scientists identify new form of dementia

May 1, 2019
Research and Development AD, Alzheimer's, dementia, late, neuroscience

A team of scientists from Britain and the United States have described a new form of dementia, according to a …

News

CBD could be used to deliver drugs into the brain, research shows

April 18, 2019
Research and Development BBB, CBD, CNS, brain, drug delivery, neuroscience

Cannabidiol (CBD), one of 113 cannabinoids in cannabis plants, could be used to deliver medicines into the brain, according to …

News
neurons-3743011_960_720

Vitamin D deficiency may cause cognitive decline through weakening brain’s scaffolding

February 26, 2019
Manufacturing and Production NPP, mental health, neurology, neuroscience, schizophrenia, vitamin d

Vitamin D deficiency may weaken supportive ‘scaffolding’ in the brain thus causing neurons difficulty in maintaining connections, according to a …

News
psm_v46_d168_mesial_view_of_the_human_brain

Drug slows brain shrinkage associated with progressive multiple sclerosis, study shows

August 30, 2018
Research and Development MS, brain, ibudilast, neuroscience, research

The multiple sclerosis drug ibudilast, slowed brain shrinkages in patients with progressive MS, a study published in the New England …

News
vagus_nerve_stimulation

Nerve stimulation treatments improve quality of life in depressed people, study shows

August 23, 2018
Research and Development VNS, depression, neuroscience, psychiatry, quality of life, vagus nerve stimulators

Nerve stimulation treatments can significantly improve depressed people’s quality of life, even in cases in which an individual continues to …

News
30614937102_31ec4db2fa_z

Prozac prevents cognitive decline during normal aging process, study shows

August 21, 2018
Manufacturing and Production MIT, Picower Institute, Prozac, antidepressants, mice, neuroscience

A study conducted by MIT’s Picower Institute for Learning and Memory has reinforced the notion that loss in the capacity …

News

Pfizer pumps $600m into venture fund, targeting neuroscience

June 7, 2018
Research and Development, Sales and Marketing Pfizer, biotech, drugs, neuroscience, pharma, pharmaceutical

Pfizer’s move to dump its neuroscience divisions caused serious ripples through the industry, with many wondering whether it heralded an …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

March 23, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Canada, Celgene, Lundbeck, Marijuana, Novartis, Roche, Vertex, brexit, cannabis, multiple sclerosis, neuroscience, pharma

As me move startlingly quickly towards Easter, it’s time for another Top Ten rundown. This week, Celgene surprised the industry …

News
celgene_1_02

Celgene bucks trend to strengthen neuroscience pipeline

March 21, 2018
Research and Development, Sales and Marketing Alzheimer's, Celgene, Prothena, biotech, drugs, neuroscience, pharma, pharmaceutical

Celgene has gone against industry movement to back out of the neuroscience area by putting down a potential $2.2 billion …

News
shire_image_4

Shire announces split into two business units, downgrades revenue forecast

January 9, 2018
Manufacturing and Production, Sales and Marketing Shire, neuroscience, pharma, rare disease

Shire has revealed that it now plans to move forward by separating its operations into two distinct divisions: rare disease …

News
Alzheimer's brain

Amgen and Novartis partner on Alzheimer’s and migraine treatments

September 2, 2015
Research and Development Alzheimer's disease, Amgen, Novartis, migraine, neurology, neuroscience

Amgen and Novartis have announced a global collaboration to develop neuroscience treatments in Alzheimer’s disease and migraine.  The companies plan …

News

Latest content

Ardena announces €20m expansion following first GMP approval

April 19, 2024

Roche’s Alecensa approved by FDA as lung cancer treatment

April 19, 2024

GSK shares results from phase 3 trial for gonorrhoea treatment

April 18, 2024

Eli Lilly’s tirzepatide demonstrates efficacy in reducing sleep apnoea severity

April 18, 2024

Medincell and AbbVie enter agreement for development of next-generation injectables

April 17, 2024